Table 1 Baseline characteristics of the recipients and donors
Variables | Graft survival (n = 76) | Graft failure (n = 26) | p-value |
|---|---|---|---|
Recipient age (years) | 34.1 ± 8.5 | 39.3 ± 9.7 | 0.05 |
Recipient sex, f/m (%) | 18/58 (24/76) | 9/17 (35/65) | 0.27 |
Recipient race, East Asian (%) | 76 (100) | 26 (100) | – |
Diabetes (%) | 14 (18.4) | 5 (19.2) | 0.93 |
SBP (mmHg) | 146.3 ± 17.6 | 149.5 ± 19.4 | 0.92 |
DBP (mmHg) | 74.4 ± 9.5 | 75.9 ± 10.5 | 0.50 |
Acute rejectiona (%) | 7 (9.2) | 4 (15.4) | 0.38 |
Delayed graft function (%) | 4 (5.2) | 2 (7.7) | 0.65 |
Anti-HLA antibodiesb (%) | 13 (17.1) | 4 (15.4) | 0.84 |
Class I (%) | 5 (6.6) | 3 (11.5) | 0.42 |
Class II (%) | 13 (17.1) | 2 (7.7) | 0.24 |
HLA mismatches (A, B, or DR) | 2.1 ± 1.1 | 1.7 ± 1.0 | 0.77 |
Therapeutic regimen | |||
 Intravenous methylprednisolone pulsesc (%) | 21 (27.6) | 7 (26.9) | 0.94 |
 Tonsillectomy (%) | 10 (13.1) | 6 (23.1) | 0.23 |
 ACEIs used (%) | 59 (77.6) | 23 (88.5) | 0.23 |
 Disease timed (years) | 4.0 ± 3.4 | 5.3 ± 3.7 | 0.62 |
 Waiting timee (months) | 0.8 ± 1.3 | 0.4 ± 0.6 | 0.14 |
 24-h urinary protein (g/24 h) | 0.3 ± 0.2 | 0.4 ± 0.3 | 0.10 |
 Urinary RBC count (u/ml) | 1.5 ± 1.8 | 2.0 ± 2.5 | 0.22 |
 Cholesterol (mmol/L) | 5.3 ± 1.5 | 5.7 ± 2.5 | 0.36 |
 LDL (mmol/L) | 3.4 ± 1.1 | 3.8 ± 1.6 | 0.16 |
 ALB (g/L) | 42.0 ± 4.4 | 40.8 ± 4.4 | 0.24 |
 eGFRf (mL/min/1.73 m^2)g | 75.2 ± 21.8 | 67.9 ± 20.7 | 0.14 |
 Donor age (years) | 50.4 ± 8.6 | 49.5 ± 8.4 | 0.77 |
 Donor sex f/m (%) | 53/23 (69/31) | 14/12 (54/46) | 0.14 |
 Donor race, East Asian (%) | 76 (100) | 26 (100) | – |